Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioMarin Pharmaceutical I...

    NASDAQ: BMRN · Real-Time Price · USD
    57.45
    -0.09 (-0.16%)
    At close: Aug 18, 2025, 3:59 PM
    58.26
    1.40%
    After-hours: Aug 18, 2025, 06:04 PM EDT

    BioMarin Pharmaceutical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.85B 2.42B 2.1B 1.85B
    Cost of Revenue
    		 580.24M 577.07M 483.67M 470.51M
    Gross Profit
    		 2.27B 1.84B 1.61B 1.38B
    Operating Income
    		 484.21M 194.44M 57.55M -60.01M
    Interest Income
    		 74.88M 58.34M 18.03M 10.48M
    Pretax Income
    		 541.76M 188.56M 149.58M -75.35M
    Net Income
    		 426.86M 167.65M 141.56M -64.08M
    Selling & General & Admin
    		 938.73M 937.3M 854.01M 759.38M
    Research & Development
    		 747.18M 746.77M 649.61M 628.79M
    Other Expenses
    		 33.28M n/a 67.19M 69.93M
    Operating Expenses
    		 1.79B 1.75B 1.57B 1.46B
    Interest Expense
    		 12.67M 17.34M 15.97M 15.34M
    Selling & Marketing Expenses
    		 34.5M 488.4M 450.3M 405.1M
    Cost & Expenses
    		 2.37B 2.27B 2.05B 1.93B
    Income Tax Expense
    		 114.9M 20.92M 8.02M -11.27M
    Shares Outstanding (Basic)
    		 190.03M 187.83M 185.27M 182.85M
    Shares Outstanding (Diluted)
    		 196.71M 191.59M 188.96M 182.85M
    EPS (Basic)
    		 2.13 0.89 0.76 -0.35
    EPS (Diluted)
    		 2.06 0.87 0.75 -0.35
    EBITDA
    		 650.86M 310.28M 267.51M 48.03M
    EBIT
    		 554.1M 205.3M 164.95M -60.61M
    Depreciation & Amortization
    		 96.43M 104.39M 101.97M 108.04M

    Add to Watchlist